US House bill would increase FDA non-user fee funding by 15%
This article was originally published in Scrip
The US House has approved a measure that would boost the FDA's non-user fee funding by 15% in fiscal 2010, bringing the agency's total budget to approximately $3 billion. The measure does not include new user fees for generic drugs or manufacturing facility re-inspections that had been requested by the Obama Administration. However, it allocates a $5 million funding increase for the generic drugs office.